INHIBITORY EFFECT OF NEUROPEPTIDE-Y (NPY) ON THE IN-VITRO ACTIVITY OF TYROSINE-HYDROXYLASE

被引:11
作者
CHENG, JT [1 ]
CHANG, CL [1 ]
TSAI, CL [1 ]
机构
[1] NATL SUN YAT SEN UNIV,DEPT MARINE RESOURCES,KAOHSIUNG 80424,TAIWAN
关键词
NEUROPEPTIDE Y; TYROSINE HYDROXYLASE; ADRENAL GLAND; CATECHOLAMINE; IN VITRO;
D O I
10.1016/0304-3940(94)91041-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuropeptide Y (NPY) is found to be costored with norepinephrine (JE) in Vesicles of the nerve terminals. Tyrosine hydroxylase (TH), the synthetic enzyme of NE, has been mentioned to be a rate-limiting step. In an attempt to understand the effect of NPY on TH activities, an in vitro assay is carried out using chromatographic analysis of 3,4-dihydroxyphenylalanine (DOPA) formation from tyrosine. NPY (40-120 pmol/ml) produced a dose-dependent depression of DOPA formation catalysed by the adrenal TK of rats. Lineweaver-Burk plot (K-m = 156 mu M, V-max = 1.05 nmol/h/mg protein) showed a non-competitive inhibition in NPY (80 pmol/ml, IC50)-treated samples. Moreover, failure of denatured NPY even at maximum concentration to influence the TH activities suggested the essential of nature form for NPY. Participation of pterine cofactor seems also negligible, because increase of 2-amino-4-hydroxy-6,7-dimethyltetrahydropteridine did not overcome the effect of NPY. These results indicate that NPY has the ability to inhibit the catalytic action of TH in the adrenal gland of rats.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 27 条
[1]   NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN [J].
ADRIAN, TE ;
ALLEN, JM ;
BLOOM, SR ;
GHATEI, MA ;
ROSSOR, MN ;
ROBERTS, GW ;
CROW, TJ ;
TATEMOTO, K ;
POLAK, JM .
NATURE, 1983, 306 (5943) :584-586
[2]   NEUROPEPTIDE-Y (NPY) IN THE ADRENAL-GLAND [J].
ALLEN, JM ;
ADRIAN, TE ;
POLAK, JM ;
BLOOM, SR .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1983, 9 (2-3) :559-563
[3]   TISSUE FRACTIONATION AND CATECHOLAMINES .3. INTRACELLULAR DISTRIBUTION OF ENDOGENOUS INHIBITORS OF DOPAMINE-BETA-HYDROXYLASE IN ADRENAL MEDULLA [J].
BELPAIRE, F ;
LADURON, P .
BIOCHEMICAL PHARMACOLOGY, 1970, 19 (04) :1323-+
[4]  
BLANK CL, 1976, LIFE SCI, V18, P859
[5]   INHIBITORY EFFECT OF NEUROPEPTIDE-Y (NPY) ON THE INVITRO ACTIVITY OF DOPAMINE-BETA-HYDROXYLASE [J].
CHENG, JT ;
CHANG, CL ;
TSAI, CL .
NEUROSCIENCE LETTERS, 1992, 136 (01) :36-38
[6]   NEUROPEPTIDE-Y IN THE ADRENAL-GLAND - CHARACTERIZATION, DISTRIBUTION AND DRUG EFFECTS [J].
DEQUIDT, ME ;
EMSON, PC .
NEUROSCIENCE, 1986, 19 (03) :1011-&
[7]   CHARACTERIZATION OF THE CONTRACTILE EFFECT OF NEUROPEPTIDE-Y IN FELINE CEREBRAL-ARTERIES [J].
EDVINSSON, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (01) :33-41
[8]   NEUROPEPTIDE-Y CO-EXISTS AND CO-OPERATES WITH NORADRENALINE IN PERIVASCULAR NERVE-FIBERS [J].
EKBLAD, E ;
EDVINSSON, L ;
WAHLESTEDT, C ;
UDDMAN, R ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1984, 8 (03) :225-235
[9]   DIFFERENTIAL CO-EXISTENCE OF NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVITY WITH CATECHOLAMINES IN THE CENTRAL NERVOUS-SYSTEM OF THE RAT [J].
EVERITT, BJ ;
HOKFELT, T ;
TERENIUS, L ;
TATEMOTO, K ;
MUTT, V ;
GOLDSTEIN, M .
NEUROSCIENCE, 1984, 11 (02) :443-&
[10]  
FRIGON RP, 1981, MOL PHARMACOL, V19, P444